Recognition underscores the impact of Proscia in advancing precision medicine from drug discovery to diagnostics PHILADELPHIA — June 3, 2025 — Proscia®, a software company accelerating pathology’s transition to digital and AI, today...

Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the development and commercialization of advanced diagnostic tools aimed at expanding precision medicine. Leveraging DHR’s newly...

At the HIMSS Conference, HistAI announced the SPIDER Initiative, an open-source project set to become the largest supervised medical imaging dataset. The initiative will compile more than 50 millions of fully annotated images from 20 organs and...

Proscia: Record year comes as the rise of precision medicine drives a surge in demand Philadelphia – January 13, 2025 – Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, more than doubled its growth in...

Proscia has announced a webinar. From Bedside to Bench and Back: How Digital Pathology is Fueling Precision Medicine with Unprecedented Real-World Data October 30 11:00 AM — 12:00 PM EDT Register Join us for a panel discussion on...

From the Proscia blog: Following a successful year-long pilot with a subset of our biopharma and biotech partners, today we announced that life sciences organizations can now leverage Proscia’s real-world data offering on the...